Published in Women's Health Weekly, May 22nd, 2003
But in recent years, researchers have also learned that ovarian cancer patients who inherit BRCA mutations may live longer than patients who do not. The reason for this survival advantage, however, has not been identified.
Now, researchers at Cedars-Sinai Medical Center have found that improved survival among patients with hereditary BRCA-associated ovarian cancer may result from a greater sensitivity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly